{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:56:01Z","timestamp":1789656961462,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"German Federal Ministry of Health and German Competence Network Adipositas","award":["n.a."],"award-info":[{"award-number":["n.a."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Childhood obesity is often associated with non-alcoholic fatty liver disease (NAFLD), the most common chronic liver disease in pediatrics.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This multi-center study analyzed liver echogenicity and liver enzymes in relation to obesity, age, gender and comorbidities. Data were collected using a standardized documentation software (APV) from 1.033 pediatric patients (age: 4\u201318\u2009years, body mass index\u2009=\u2009BMI: 28\u201336\u2009kg\/m<jats:sup>2<\/jats:sup>, 50% boys) with overweight (BMI &gt;90th percentile), obesity (BMI &gt;97th percentile) or extreme obesity (BMI &gt;\u200999.5th percentile) and obesity related comorbidities, especially NAFLD from 26 centers of Germany, Austria and Switzerland. Liver enzymes aspartate aminotransferase (AST), alanine-aminotransferase (ALT) and gamma glutamyltransferase (gammaGT) were evaluated using 2 cut-off values a) &gt;\u200925\u2009U\/L and b) &gt;\u200950\u2009U\/L. Multiple logistic regression models were used for statistical analysis.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 44% of the patients showed increased liver echogenicity. Liver enzymes &gt;\u200925\u2009U\/L were present in 64% and\u2009&gt;\u200950\u2009U\/L in 17%. Increased liver echogenicity was associated with elevated liver enzymes (&gt;\u200925\u2009U\/L: odds ratio (OR)\u2009=\u20091.4, 95% CI: 1.1\u20131.9, <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.02; &gt;\u200950\u2009U\/L: OR\u2009=\u20093.5, 95% CI: 2.4\u20135.1, <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.0001). Extreme obesity, adolescence and male gender were associated with increased liver echogenicity (extreme obesity vs overweight OR\u2009=\u20093.5, 95% CI: 1.9\u20136.1, <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.0001; age\u2009&gt;\u200914\u2009years vs age\u2009&lt;\u20099\u2009years OR\u2009=\u20092.2, 95% CI: 1.4\u20133.5, <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.001; boys vs girls OR\u2009=\u20091.6, 95% CI: 1.2\u20132.0, <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.001) and elevated liver enzymes (extreme obesity vs overweight &gt;\u200925\u2009U\/L: OR\u2009=\u20094.1, 95% CI: 2.4\u20136.9, <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.0001; &gt;\u200950\u2009U\/L: OR\u2009=\u200918.5, 95% CI: 2.5\u2013135, <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.0001; age\u2009&gt;\u200914\u2009years vs age\u2009&lt;\u20099\u2009years &gt;\u200950\u2009U\/L: OR\u2009=\u20091.9, 95% CI: 1.0\u20133.7, <jats:italic>P<\/jats:italic>\u00a0&gt;\u20090.05; boys vs girls &gt;\u200925\u2009U\/L: OR\u2009=\u20093.1, 95% CI: 2.4\u20134.1, <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.0001; &gt;\u200950\u2009U\/L: OR\u2009=\u20092.1, 95% CI: 1.5\u20132.9, <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.0001). Impaired glucose metabolism showed a significant correlation with elevated liver enzymes &gt;\u200950\u2009U\/L (OR\u2009=\u20094.4, 95% CI: 1.6\u201311.8, <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.005). Arterial hypertension seemed to occur in patients with elevated liver enzymes &gt;\u200925\u2009U\/L (OR 1.6, 95% CI: 1.2\u20132.0, <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.005).<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>NAFLD is strongly related to extreme obesity in male adolescents. Moreover impaired glucose tolerance was observed in patients with elevated liver enzymes &gt;\u200950\u2009U\/L, but arterial hypertension was only present in patients with moderately elevated liver enzymes &gt;\u200925\u2009U\/L.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-019-1711-4","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T03:02:53Z","timestamp":1568257373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Increased liver echogenicity and liver enzymes are associated with extreme obesity, adolescent age and male gender: analysis from the German\/Austrian\/Swiss obesity registry APV"],"prefix":"10.1186","volume":"19","author":[{"name":"on behalf of the APV-Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Greber-Platzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Thajer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Bohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Brunert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicitas","family":"Boerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Siegfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Artlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Moeckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegunde","family":"Waldecker-Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Pauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard W.","family":"Holl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,12]]},"reference":[{"key":"1711_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/jamapediatrics.2014.2702","volume":"169","author":"V Nobili","year":"2015","unstructured":"Nobili V, Alkhouri N, Alisi A, Della Corte C, Fitzpatrick E, Raponi M, et al. Nonalcoholic fatty liver disease: a challenge for pediatricians. JAMA Pediatr. 2015;169:170\u20136. \n                    https:\/\/doi.org\/10.1001\/jamapediatrics.2014.2702\n                    \n                  .","journal-title":"JAMA Pediatr"},{"key":"1711_CR2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1001\/jama.2012.40","volume":"307","author":"CL Ogden","year":"2012","unstructured":"Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA. 2012;307:483\u201390. \n                    https:\/\/doi.org\/10.1001\/jama.2012.40\n                    \n                  .","journal-title":"JAMA"},{"key":"1711_CR3","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s001120170107","volume":"149","author":"K Kromeyer-Hauschild","year":"2001","unstructured":"Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Gei\u00df HC, Hesse V, et al. Perzentile f\u00fcr den Body-mass-Index f\u00fcr das Kindes- und Jugend-alter unter Heranziehung verschiedener deutscher Stichproben. Monatsschrift Kinderheilkunde. 2001;149:807\u201318.","journal-title":"Monatsschrift Kinderheilkunde"},{"key":"1711_CR4","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1542\/peds.2006-1212","volume":"118","author":"JB Schwimmer","year":"2006","unstructured":"Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388\u201393.","journal-title":"Pediatrics"},{"key":"1711_CR5","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005\u201323. \n                    https:\/\/doi.org\/10.1002\/hep.25762\n                    \n                  .","journal-title":"Hepatology"},{"key":"1711_CR6","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"European Association for the Study of the Liver (EASL)1, European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO)","year":"2016","unstructured":"European Association for the Study of the Liver (EASL)1, European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388\u2013402. \n                    https:\/\/doi.org\/10.1016\/j.jhep.2015.11.004\n                    \n                  .","journal-title":"J Hepatol"},{"key":"1711_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","volume":"103","author":"JK Dowman","year":"2010","unstructured":"Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. QJM. 2010;103:71\u201383. \n                    https:\/\/doi.org\/10.1093\/qjmed\/hcp158\n                    \n                  .","journal-title":"QJM"},{"key":"1711_CR8","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/ijo.2010.185","volume":"34","author":"K Widhalm","year":"2010","unstructured":"Widhalm K, Ghods E. Nonalcoholic fatty liver disease: a challenge for pediatricians. Int J Obes. 2010;34:1451\u201367. \n                    https:\/\/doi.org\/10.1038\/ijo.2010.185\n                    \n                  .","journal-title":"Int J Obes"},{"key":"1711_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1172\/JCI200422422","volume":"114","author":"JD Browning","year":"2004","unstructured":"Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004;114:147\u201352.","journal-title":"J Clin Invest"},{"key":"1711_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000282086","volume":"28","author":"BK Straub","year":"2010","unstructured":"Straub BK, Schirmacher P. Pathology and biopsy assessment of non-alcoholic fatty liver disease. Dig Dis. 2010;28:197\u2013202. \n                    https:\/\/doi.org\/10.1159\/000282086\n                    \n                  .","journal-title":"Dig Dis"},{"key":"1711_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2431-13-40.0","volume":"13","author":"V Giorgio","year":"2013","unstructured":"Giorgio V, Prono F, Graziano F, Nobili V. Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets. BMC Pediatr. 2013;13:40. \n                    https:\/\/doi.org\/10.1186\/1471-2431-13-40.0\n                    \n                  .","journal-title":"BMC Pediatr"},{"key":"1711_CR12","first-page":"596","volume-title":"Ultraschalldiagnostik in P\u00e4diatrie und Kinderchirurgie","author":"V Hoffmann","year":"2014","unstructured":"Hoffmann V, Deeg KH, Hyoer PF. Akute Hepatitis. In: Ultraschalldiagnostik in P\u00e4diatrie und Kinderchirurgie. 4 eidtion ed. Germany: Thieme; 2014. p. 596.","edition":"4 eidtion"},{"key":"1711_CR13","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jhep.2016.05.038","volume":"65","author":"E Bugianesi","year":"2016","unstructured":"Bugianesi E, Rosso C, Cortez-Pinto H. How to diagnose NAFLD in 2016. J Hepatol. 2016;65:643\u20134.","journal-title":"J Hepatol"},{"key":"1711_CR14","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/ijo.2010.106","volume":"34","author":"S Wiegand","year":"2010","unstructured":"Wiegand S, Keller KM, Robl M, L'Allemand D, Reinehr T, Widhalm K, Holl RW, et al. Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16,390 overweight or obese children and adolescents. Int J Obes (Lond). 2010;34:1468\u201374. \n                    https:\/\/doi.org\/10.1038\/ijo.2010.106\n                    \n                  .","journal-title":"Int J Obes (Lond)"},{"key":"1711_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.7861\/clinmedicine.15-2-186","volume":"15","author":"NN Than","year":"2015","unstructured":"Than NN, Newsome PN. Non-alcoholic fatty liver disease: when to intervene and with what. Clin Med (Lond). 2015;15:186\u201390. \n                    https:\/\/doi.org\/10.7861\/clinmedicine.15-2-186\n                    \n                  .","journal-title":"Clin Med (Lond)"},{"key":"1711_CR16","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.pcl.2017.01.008","volume":"64","author":"PKC Selvakumar","year":"2017","unstructured":"Selvakumar PKC, Kabbany MN, Nobili V, Alkhouri N. Nonalcoholic fatty liver disease in children: hepatic and extrahepatic complications. Pediatr Clin N Am. 2017;64:659\u201375. \n                    https:\/\/doi.org\/10.1016\/j.pcl.2017.01.008\n                    \n                  .","journal-title":"Pediatr Clin N Am"},{"key":"1711_CR17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2015;149:389\u201397.e10. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2015.04.043\n                    \n                  .","journal-title":"Gastroenterology"},{"key":"1711_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/MOP.0b013e32832cb16f","volume":"21","author":"SS Sundaram","year":"2009","unstructured":"Sundaram SS, Zeitler P, Nadeau K. The metabolic syndrome and nonalcoholic fatty liver disease in children. Curr Opin Pediatr. 2009;21:529\u201335. \n                    https:\/\/doi.org\/10.1097\/MOP.0b013e32832cb16f\n                    \n                  .","journal-title":"Curr Opin Pediatr"},{"key":"1711_CR19","first-page":"1433","volume":"55","author":"V Tahan","year":"2008","unstructured":"Tahan V, Canbakan B, Balci H, Dane F, Akin H, Can G, Hatemi I, et al. serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk. Hepatogastroenterology. 2008;55:1433\u20138.","journal-title":"Hepatogastroenterology"},{"key":"1711_CR20","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1097\/MPG.0b013e318252a13f","volume":"54","author":"P Vajro","year":"2012","unstructured":"Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN hepatology committee. J Pediatr Gastroenterol Nutr. 2012;54:700\u201313. \n                    https:\/\/doi.org\/10.1097\/MPG.0b013e318252a13f\n                    \n                  .","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1711_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/MPG.0b013e3181f8417f","volume":"52","author":"S Wiegand","year":"2011","unstructured":"Wiegand S, Thamm M, Kiess W, Korner A, Reinehr T, Krude H, et al. Gamma-glutamyl transferase is strongly associated with degree of overweight and sex. J Pediatr Gastroenterol Nutr. 2011;52:635\u20138. \n                    https:\/\/doi.org\/10.1097\/MPG.0b013e3181f8417f\n                    \n                  .","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1711_CR22","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.2337\/dc11-9997","volume":"34","author":"DB Sacks","year":"2011","unstructured":"Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Position statement executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care. 2011;34:1419\u201323. \n                    https:\/\/doi.org\/10.2337\/dc11-9997\n                    \n                  .","journal-title":"Diabetes Care"},{"key":"1711_CR23","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1542\/peds.2009-2107C","volume":"128","author":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute","year":"2011","unstructured":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128:S213\u201356. \n                    https:\/\/doi.org\/10.1542\/peds.2009-2107C\n                    \n                  .","journal-title":"Pediatrics"},{"key":"1711_CR24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S1542-3565(05)00978-X","volume":"4","author":"S Xanthakos","year":"2006","unstructured":"Xanthakos S, Miles L, Bucuvalas J, Daniels S, Garcia V, Inge T. Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents. Clin Gastroenterol Hepatol. 2006;4:226\u201332.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1711_CR25","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","volume":"51","author":"S Dasarathy","year":"2009","unstructured":"Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, McCullough AJ. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol. 2009;51:1061\u20137. \n                    https:\/\/doi.org\/10.1016\/j.jhep.2009.09.001\n                    \n                  .","journal-title":"J Hepatol"},{"key":"1711_CR26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/MPG.0b013e31821b4b61","volume":"53","author":"A Shannon","year":"2011","unstructured":"Shannon A, Alkhouri N, Carter-Kent C, Monti L, Devito R, Lopez R, et al. Ultrasonographic quantitative estimation of hepatic steatosis in children with NAFLD. J Pediatr Gastroenterol Nutr. 2011;53:190\u20135. \n                    https:\/\/doi.org\/10.1097\/MPG.0b013e31821b4b61\n                    \n                  .","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1711_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021178","volume":"6","author":"H Poustchi","year":"2011","unstructured":"Poustchi H, George J, Esmaili S, Esna-Ashari F, Ardalan G, Sepanlou SG, et al. Gender differences in healthy ranges for serum alanine aminotransferase levels in adolescence. PLoS One. 2011;6:e21178. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0021178\n                    \n                  .","journal-title":"PLoS One"},{"key":"1711_CR28","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1053\/j.gastro.2009.12.052","volume":"138","author":"JB Schwimmer","year":"2010","unstructured":"Schwimmer JB, Dunn W, Norman GJ, Pardee PE, Middleton MS, Kerkar N, et al. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology. 2010;138:1357\u201364, 1364.e1\u20132. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2009.12.052\n                    \n                  .","journal-title":"Gastroenterology"},{"key":"1711_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12519-018-0126-x","volume":"14","author":"X Li","year":"2018","unstructured":"Li X, Wang D, Yang C, Zhou Q, Zhuoga SL, Wang LQ, et al. Establishment of age- and gender-specific pediatric reference intervals for liver function tests in healthy Han children. World J Pediatr. 2018;14:151\u20139. \n                    https:\/\/doi.org\/10.1007\/s12519-018-0126-x\n                    \n                  .","journal-title":"World J Pediatr"},{"key":"1711_CR30","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/j.1478-3231.2011.02673.x","volume":"32","author":"M Franzini","year":"2012","unstructured":"Franzini M, Fornaciari I, Fierabracci V, Elawadi HA, Bolognesi V, Maltinti S, et al. Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. Liver Int. 2012;32:629\u201334. \n                    https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02673.x\n                    \n                  .","journal-title":"Liver Int"},{"key":"1711_CR31","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1002\/jcb.24051","volume":"113","author":"R Dai","year":"2012","unstructured":"Dai R, Yan D, Li J, Chen S, Liu Y, Chen R, et al. Activation of PKR\/eIF2alpha signaling cascade is associated with dihydrotestosterone-induced cell cycle arrest and apoptosis in human liver cells. J Cell Biochem. 2012;113:1800\u20138. \n                    https:\/\/doi.org\/10.1002\/jcb.24051\n                    \n                  .","journal-title":"J Cell Biochem"},{"key":"1711_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1365-2265.2006.02543.x","volume":"65","author":"J McKenzie","year":"2006","unstructured":"McKenzie J, Fisher BM, Jaap AJ, Stanley A, Paterson K, Sattar N. Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. Clin Endocrinol (Oxf). 2006;65:40\u20134.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1711_CR33","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/ijo.2017.50","volume":"41","author":"S Hart-Unger","year":"2017","unstructured":"Hart-Unger S, Arao Y, Hamilton KJ, Lierz SL, Malarkey DE, Hewitt SC, et al. Hormone signaling and fatty liver in females: analysis of estrogen receptor alpha mutant mice. Int J Obes. 2017;41:945\u201354. \n                    https:\/\/doi.org\/10.1038\/ijo.2017.50\n                    \n                  .","journal-title":"Int J Obes"},{"key":"1711_CR34","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1053\/j.gastro.2007.08.077","volume":"133","author":"A Fraser","year":"2007","unstructured":"Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology. 2007;133:1814\u201320.","journal-title":"Gastroenterology"},{"key":"1711_CR35","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1203\/01.pdr.0000246097.73031.27","volume":"60","author":"TS Hannon","year":"2006","unstructured":"Hannon TS, Janosky J, Arslanian SA. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res. 2006;60:759\u201363.","journal-title":"Pediatr Res"},{"key":"1711_CR36","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.clinimag.2012.07.011","volume":"37","author":"M Akcam","year":"2013","unstructured":"Akcam M, Boyaci A, Pirgon O, Koroglu M, Dundar BN. Importance of the liver ultrasound scores in pubertal obese children with nonalcoholic fatty liver disease. Clin Imaging. 2013;37:504\u20138. \n                    https:\/\/doi.org\/10.1016\/j.clinimag.2012.07.011\n                    \n                  .","journal-title":"Clin Imaging"},{"key":"1711_CR37","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3748\/wjg.v17.i6.735","volume":"17","author":"JF Fu","year":"2011","unstructured":"Fu JF, Shi HB, Liu LR, Jiang P, Liang L, Wang CL, et al. Non-alcoholic fatty liver disease: an early mediator predicting metabolic syndrome in obese children? World J Gastroenterol. 2011;17:735\u201342. \n                    https:\/\/doi.org\/10.3748\/wjg.v17.i6.735\n                    \n                  .","journal-title":"World J Gastroenterol"},{"key":"1711_CR38","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2337\/dc10-0284","volume":"33","author":"E D'Adamo","year":"2010","unstructured":"D'Adamo E, Cali AM, Weiss R, Santoro N, Pierpont B, Northrup V, et al. Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care. 2010;33:1817\u201322. \n                    https:\/\/doi.org\/10.2337\/dc10-0284\n                    \n                  .","journal-title":"Diabetes Care"},{"key":"1711_CR39","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1002\/hep.22858","volume":"49","author":"AM Cali","year":"2009","unstructured":"Cali AM, De Oliveira AM, Kim H, Chen S, Reyes-Mugica M, Escalera S, et al. Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link? Hepatology. 2009;49:1896\u2013903. \n                    https:\/\/doi.org\/10.1002\/hep.22858\n                    \n                  .","journal-title":"Hepatology"},{"key":"1711_CR40","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/hep.21327","volume":"44","author":"M Ekstedt","year":"2006","unstructured":"Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865\u201373.","journal-title":"Hepatology"},{"key":"1711_CR41","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1055\/s-0028-1091983","volume":"28","author":"A Wieckowska","year":"2008","unstructured":"Wieckowska A, Feldstein AE. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis. 2008;28:386\u201395. \n                    https:\/\/doi.org\/10.1055\/s-0028-1091983\n                    \n                  .","journal-title":"Semin Liver Dis"},{"key":"1711_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11894-016-0498-9","volume":"18","author":"V Uppal","year":"2016","unstructured":"Uppal V, Mansoor S, Furuya KN. Pediatric non-alcoholic fatty liver disease. Curr Gastroenterol Rep. 2016;18:24. \n                    https:\/\/doi.org\/10.1007\/s11894-016-0498-9\n                    \n                  .","journal-title":"Curr Gastroenterol Rep"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1711-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-019-1711-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1711-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T19:17:23Z","timestamp":1599765443000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-019-1711-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,12]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1711"],"URL":"https:\/\/doi.org\/10.1186\/s12887-019-1711-4","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,12]]},"assertion":[{"value":"26 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is based on pseudonymized data (de-facto anonymized as no re-identification of subjects is possible) provided by participating centers for quality improvement and outcome research. After clarification of queries with the participating institution, at the latest 4\u2009weeks after transmission of the data, these were completely anonymized without any possibility to re-identify a subject even at the treatment center. All participating institutions confirmed electronically that data collection. Germany is a Federal country, and the federal states are responsible for data protection, therefore rules and regulations do differ between each states. All participants - or in case of minors their legal guardians - agreed to contribute their routine clinical data for the joint analysis. The local institutional review boards at each participating center decided whether consent was obtained written or verbally. All data analyzed are from routine care based on current guidelines, no additional tests or information solely for this study was provided by the centers. All data were collected prior to the introduction of the EU General Data Protection Regulation (GDPR). The study was approved by the Ethics-Committee of Ulm University (reference number: 187\/09) acting as Lead Ethics-Committee with validity for all participating institutions from Germany and for Austria (Dornbirn Kinderklinik and Wien Universit\u00e4tsklinik f\u00fcr Kinder- und Jugendheilkunde - Ambulanz f\u00fcr Adipositas, Fettstoffwechselst\u00f6rungen und Ern\u00e4hrungsmedizin) a confirmation was obtained from the Austrian Lead Ethics-Committee of the Medical University Vienna, Austria.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}